Patent Assignment
Reel/Frame 059500/0793
Assignment of Assignor's Interest
Recorded: 2022-03-25
Pages: 119
Assignor
THE PROCTER & GAMBLE COMPANY
Executed: 2009-10-30
Assignee
WARNER CHILCOTT COMPANY, LLC
UNION STREET, KM1.1, FAJARDO, PUERTO RICO, 00738
Covered Properties
(6)
Prolyl Hydroxylase Inhibitors and Methods of Use
Prolyl Hydroxylase Inhibitors and Methods of Use
Prolyl Hydroxylase Inhibitors and Methods of Use
Prolyl Hydroxylase Inhibitors and Method of Use
Prolyl Hydroxylase Inhibitors and Methods of Use
Prolyl Hydroxylase Inhibitors and Methods of Use
Patent:
47,437 →
Application:
15/875,495 →
Related Assignments
(9)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Agreement
Mar 30, 2011
From: WARNER CHILCOTT COMPANY LLC
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 026064/0607 →
Patent Release
Dec 23, 2011
From: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
To: WARNER CHILCOTT COMPANY, LLC
Reel/Frame 027443/0164 →
Assignment of Assignor's Interest
Dec 27, 2011
From: WARNER CHILCOTT COMPANY, LLC
To: AKEBIA THERAPEUTICS INC.
Reel/Frame 027445/0100 →
Release of Security Interest
Oct 31, 2013
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: WARNER CHILCOTT COMPANY, LLC
Reel/Frame 031531/0538 →
Assignment of Assignor's Interest
Mar 25, 2022
From: WARNER CHILCOTT COMPANY, LLC
To: AKEBIA THERAPEUTICS, INC.
Reel/Frame 059399/0199 →
Assignment of Assignor's Interest
Mar 25, 2022
From: KAWAMOTO, RICHARD MASARU
To: THE PROCTER & GAMBLE COMPANY
Reel/Frame 059398/0372 →
Assignment of Assignor's Interest
Mar 25, 2022
From: WU, SHENGDE; WARSHAKOON, NAMAL C.; EVDOKIMOV, ARTEM G.; GREIS, KENNETH D.
To: THE PROCTER & GAMBLE COMPANY
Reel/Frame 059398/0761 →
Security Interest
Jan 29, 2024
From: AKEBIA THERAPEUTICS, INC.; KERYX BIOPHARMACEUTICALS, INC.
To: KREOS CAPITAL VII (UK) LIMITED
Reel/Frame 066377/0654 →
Corrective Assignment to Correct the the Receiving Party Name Previously Recorded at Reel: 27445 Frame: 100. Assignor(S) Hereby Confirms the Assignment.
May 17, 2024
From: WARNER CHILCOTT COMPANY, LLC
To: AKEBIA THERAPEUTICS, INC.
Reel/Frame 067456/0592 →